Elanco Animal Health (ELAN) Shares Outstanding (Weighted Average) (2017 - 2026)

Elanco Animal Health has disclosed Shares Outstanding (Weighted Average) across 10 years of filings, most recently posting $497.7 million for Q1 2026.

• Shares Outstanding (Weighted Average) for Q1 2026 came in at $497.7 million, up 0.53% year-over-year; the trailing twelve-month figure through Mar 2026 was $497.7 million (up 0.53% YoY), and the FY2025 annual result was $496.4 million, changed 0.49% from the prior year.
• Shares Outstanding (Weighted Average) came in at $497.7 million for Q1 2026 at Elanco Animal Health, roughly flat from $496.4 million in the prior quarter.
• In the past five years, Shares Outstanding (Weighted Average) ranged from a high of $497.7 million in Q1 2026 to a low of $488.0 million in Q1 2022.
• The 5-year median for Shares Outstanding (Weighted Average) is $493.2 million (2024), against an average of $492.8 million.
• Across the five-year window, Shares Outstanding (Weighted Average) climbed 0.18% in 2022 and rose 0.9% in 2023, its largest moves.
• Elanco Animal Health's Shares Outstanding (Weighted Average) stood at $488.3 million in 2022, then gained by 0.82% to $492.3 million in 2023, then climbed by 0.35% to $494.0 million in 2024, then increased by 0.49% to $496.4 million in 2025, then advanced by 0.26% to $497.7 million in 2026.
• The last three Shares Outstanding (Weighted Average) figures came in at $497.7 million (Q1 2026), $496.4 million (Q4 2025), and $496.8 million (Q3 2025), per Business Quant data.